Individuals using obesity medications such as Mounjaro or Wegovy are likely to regain almost two-thirds of the weight they lose within a year of stopping the drugs, a new study suggests.
While this period of post-treatment weight gain is expected to plateau, patients typically manage to keep a quarter of the weight lost off.
